Valuation BioSenic SA

Stocks

Market Closed - Euronext Bruxelles 11:55:00 2026-09-11 EDT			5-day change	1st Jan Change
0.002000 ^EUR	0.00%		0.00%	-13.04%

25-10-27	BioSenic S.A. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-10-02	BioSenic S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024
Market Cap ¹	2.998	9.987	1.879
Change	-	233.11%	-81.19%
Enterprise Value (EV) ¹	24.94	38.03	29.21
Change	-	52.47%	-23.17%
P/E	-5.65x	-0.29x	-0.28x
PBR	6.54x	-0.44x	-0.07x
PEG	-	-0x	0x
Capitalization / Revenue	10.1x	29.7x	18.4x
EV / Revenue	84.3x	113x	286x
EV / EBITDA	-10.8x	-5.43x	-5.94x
EV / EBIT	-10.8x	-5.4x	-5.61x
EV / FCF	-13.3x	-17x	-7.16x
FCF Yield	-7.49%	-5.89%	-14%
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-0.017	-0.2102	-0.0206
Distribution rate	-	-	-
Net sales ¹	0.296	0.336	0.102
EBITDA ¹	-2.299	-6.998	-4.915
EBIT ¹	-2.318	-7.039	-5.206
Net income ¹	-2.041	-28.78	-4.768
Net Debt ¹	21.94	28.04	27.34
Reference price ²	0.096000	0.061200	0.005800
Nbr of stocks (in thousands)	31,229	163,181	323,932
Announcement Date	7/12/24	7/12/24	10/3/25

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIOSENIC SA	-	-	-	-	1.52M
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	994B
JOHNSON & JOHNSON	29.54x	-	-	2.02%	640B
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	454B
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	337B
NOVARTIS AG	19.41x	5.08x	12.59x	3.21%	261B
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	246B
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	204B
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	190B
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	178B
Average	16.16x	6.27x	15.06x	2.51%	350.48B
Weighted average by Cap.	23.19x	7.72x	17.10x	2.05%